Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ning-Lin Ge"'
Autor:
Feng Zhang, Shen-Xin Lu, Ke-Shu Hu, Yu-Hong Gan, Yi Chen, Ning-Lin Ge, Bi-Wei Yang, Lan Zhang, Rong-Xin Chen, Zheng-Gang Ren, Xin Yin
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1-10 (2021)
Objective Albumin-to-alkaline phosphatase ratio (AAPR), a newly developed blood biomarker, has been reported to have prognostic value in several types of cancer. This study aimed to investigate the predictive value of AAPR in patients with early-stag
Externí odkaz:
https://doaj.org/article/906b8ec935534ae1b09492e7a78a20a9
Autor:
Shenxin Lu, Yi Chen, Xin Yin, Yu-Hong Gan, Zhenggang Ren, Rongxin Chen, Bi-wei Yang, Ning-lin Ge, Lan Zhang, Feng Zhang, Keshu Hu
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1-10 (2021)
Objective Albumin-to-alkaline phosphatase ratio (AAPR), a newly developed blood biomarker, has been reported to have prognostic value in several types of cancer. This study aimed to investigate the predictive value of AAPR in patients with early-stag
Autor:
Bo-heng Zhang, Yu-Hong Gan, Yan-Hong Wang, Rongxin Chen, Yan Wang, Zhenggang Ren, Sheng-long Ye, Yi Chen, Ning-lin Ge, Jian-Feng Luo, Hui Ma
Publikováno v:
Journal of Gastroenterology and Hepatology. 31:442-449
Background and Aim: Radiofrequency ablation (RFA) is recommended as one of the standard treatments for early hepatocellular carcinoma (HCC). Because of high-risk tumor locations unfit for RFA, transarterial chemoembolization (TACE) is served as an al
Autor:
Bo-Heng Zhang, Ning-lin Ge, Yan-Hong Wang, Yi Chen, Zhenggang Ren, Bei Tang, Xin Yin, Lan Zhang, Yu-Hong Gan, Rongxin Chen
Publikováno v:
Journal of Clinical Oncology. 37:4077-4077
4077 Background: To determine treatment efficacy and safety of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) (hereafter, TACE+RFA) in patients with intermediate stage (BCLC stage B) hepatocellular carcinoma (HCC)
Autor:
Yu-Hong Gan, Yi Chen, Li-Xin Li, Zhenggang Ren, Yan-Hong Wang, Sheng-Long Ye, Bi-wei Yang, Xiangdong Wang, Rongxin Chen, Ning-lin Ge, Jing-Huai Zou, Bo-Heng Zhang, Diane Wang, Jinglin Xia
Publikováno v:
European Journal of Radiology. 79:196-200
Radiofrequency ablation (RFA) as a local therapy for liver cancer is widely used. The study is to evaluate the therapeutic efficacy of RFA on hepatocellular carcinoma (HCC) and identify the risk factors for recurrence. Clinical records of 124 patient
Autor:
Ning-lin Ge, Jia Yuan, Tong-Chun Xue, Yi Chen, Zhenggang Ren, Lan Zhang, Bei Tang, Bi-wei Yang, Rongxin Chen, Xin Yin, Bo-Heng Zhang, Yan-Hong Wang, Yu-Hong Gan, Li-Xin Li, Miao Li
Publikováno v:
Journal of Clinical Oncology. 36:e16115-e16115
e16115Background: Patients with advanced stage hepatocellular carcinoma (HCC) have a dismal prognosis. The Barcelona Clinic Liver Cancer (BCLC) staging system does not recommend transarterial chemo...
Publikováno v:
Journal of Clinical Oncology. 36:e16128-e16128
e16128Background: The prognosis of patients with intermediate hepatocellular carcinoma (HCC) treated by conventional TACE (cTACE) varies greatly. This study aimed to develop a new survival predicti...
Autor:
Rong-xin, Chen, Yu-hong, Gan, Ning-lin, Ge, Yi, Chen, Hui, Ma, Yan, Wang, Bo-heng, Zhang, Yan-hong, Wang, Sheng-long, Ye, Jian-feng, Luo, Zheng-gang, Ren
Publikováno v:
Journal of gastroenterology and hepatology. 31(2)
Radiofrequency ablation (RFA) is recommended as one of the standard treatments for early hepatocellular carcinoma (HCC). Because of high-risk tumor locations unfit for RFA, transarterial chemoembolization (TACE) is served as an alternative option in
Autor:
Ju-Bo Zhang, Bo-Heng Zhang, Xin Yin, Yan-Hong Wang, Yi Chen, Xiaoying Xie, Rongxin Chen, Yu-Hong Gan, Ning-lin Ge, Sheng-Long Ye, Zhenggang Ren, Lan Zhang
Publikováno v:
Medical oncology (Northwood, London, England). 32(3)
Radiofrequency ablation (RFA) has been used as a curative therapy for small hepatocellular carcinoma (HCC). However, relatively little is known about the long-term outcome of RFA for small HCC in a background of hepatitis B infection, which is common
Autor:
Ning-lin Ge, Jinglin Xia, Yu-Hong Gan, Zhao-You Tang, Bing-Hui Yang, Sheng-Long Ye, Zeng-Chen Ma, Xin-Da Zhou, Zhiying Lin, Zhenggang Ren, Dilip Sharma, Jia Fan, Zhi-Quan Wu, Lun-Xiu Qin, Yi Chen
Publikováno v:
European Journal of Radiology. 59:407-412
Objective To study severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Methods Clinical records of severe and rare complications following TACE in 1348 cases of liver cancer from January 1997 to February 2004 wer